6th-Feb-2012 15:42
Source: NSE
AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2011.
25th-Jan-2012 07:35
Source: NSE
AstraZeneca Pharma India Limited
Astrazeneca Pharma India Limited has informed the Exchange that Mr. Raghunath Rath, Company Secretary and Compliance Officer of the Company ceased to be so w.e.f. closure of business hour on January 0...
15th-Dec-2011 15:41
Source: NSE
AstraZeneca Pharma India Limited
Astrazeneca Pharma India Limited has informed the Exchange that the Board in its meeting held on November 10, 2011, appointed Ms. Ruby Lau as a Whole Time Director of the Company for a period of 2(two...
11th-Nov-2011 11:25
Source: NSE
AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2011.
11th-Nov-2011 09:50
Source: NSE
AstraZeneca Pharma India Limited
Astrazeneca Pharma India Limited has informed the Exchange that at the Board Meeting of the Company held on November 10, 2011, the Directors approved the following: (1) Ms. Ruby Lau, VP-Operations was...
11th-Nov-2011 09:22
Source: BSE
AstraZeneca- Outcome of Board Meeting
AstraZeneca Pharma India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 10, 2011, has approved the following:
- Ms. Ruby Lau, VP-Operations was...
4th-Oct-2011 18:30
Source: NSE
AstraZeneca Pharma India Limited-Updates
Astrazeneca Pharma India Limited has informed the Exchange that the Board in its meeting held on September 14, 2011, re-appointed Mr. Anandh Balasundaram as the Managing Director of the Company for a ...